Federal Register / Vol. 87, No. 97 / Thursday, May 19, 2022 / Notices 30495 

Washington, DC 20427. Please note that 

at this time, mail is sometimes delayed. 

Therefore, we encourage emailed 

comments. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Cudahy, 202–606–8090, register@

fmcs.gov. 

SUPPLEMENTARY INFORMATION: Copies of 

the proposed questions are available 

below. Paper copies are available by 

emailing register@fmcs.gov. Please ask 

for the Stakeholder Survey. 

I. Information Collection Request 

Agency: Federal Mediation and 

Conciliation Service. 

Form Number: Not yet assigned. 

Type of Request: New collection; 

generic clearance. 

Affected Entities: Private sector; state, 

local, and tribal governments; 

individuals or households; and federal 

government. 

Frequency: These methods of 

engagement are utilized on an as-needed 

basis. Each engagement is completed 

once. 

Abstract: Pursuant to the 

Administrative Dispute Resolution Acts 

of 1990 and 1996, 5 U.S.C. 561 et seq. 

and 571 et seq., and 29 U.S.C. 173(f), the 

Federal Mediation and Conciliation 

Service provides conflict prevention, 

management, and resolution services, 

including, but not limited to, public 

policy facilitation and mediation 

services, to Federal agencies. As part of 

these services, sometimes FMCS 

employees need to survey or ask 

questions to determine the best process 

and participants to prevent, manage, or 

resolve the issue, particularly for public 

policy mediations, public policy or 

environmental facilitations, or 

negotiated rulemaking. To do so, FMCS 

has created a set of questions to ask 

various stakeholders about issues, 

concerns, engagement, and appropriate 

stakeholders relevant to the issues. The 

survey format will differ depending on 

the project but may be conducted in one 

or more of the following ways, both inperson and virtually: Individual or 

group interviews, individual or group 

discussions, or written surveys. The 

survey requests information such as 

stakeholder understanding of the 

particular issue, stakeholder interests in 

the particular issue, appropriate 

stakeholders, methods of engagement 

with the issue, and other similar 

information that will allow FMCS to 

best create a successful process. A link 

to the survey is found here: https://

tags.fmcs.gov/4DAction/FC/ 

DoAsynchTop?Fedreg*UPPJ*919/10300. 

To log in, go to: https://tags.fmcs.gov/, 

use username ‘‘Fedreg’’ and password 

‘‘UPPJ.’’ The collection of such 

information is critical for ensuring the 

appropriate process, stakeholders, and 

stakeholder input in the process. No 

other collections are being conducted 

that would provide this information to 

FMCS. 

Burden: The current total annual 

burden estimate is that FMCS will 

receive information from approximately 

15,000 respondents per year. Interviews 

and discussions would be 

approximately thirty minutes in 

duration. Written surveys would take 

approximately ten minutes to complete. 

FMCS expects the total burden to not 

exceed 2,535 hours per year. 

II. Request for Comments 

FMCS solicits comments to: 

i. Evaluate whether the proposed 

collections of information are necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility. 

ii. Enhance the accuracy of the 

agency’s estimates of the burden of the 

proposed collection of information. 

iii. Enhance the quality, utility, and 

clarity of the information to be 

collected. 

iv. Minimize the burden of the 

collections of information on those who 

are to respond, including the use of 

appropriate automated, electronic 

collection technologies or other forms of 

information technology. 

III. 60-Day Comment Period 

This information was previously 

published in the Federal Register on 

March 16, 2022, allowing for a 60-day 

public comment period under 

Document 2022–05543 at 87 FR 14857. 

FMCS received no comments. 

IV. The Official Record 

The official records are electronic 

records. 

List of Subjects 

Information Collection Requests. 

Dated: May 13, 2022. 

Anna Davis, 

Acting General Counsel. 

[FR Doc. 2022–10752 Filed 5–18–22; 8:45 am] 

BILLING CODE 6732–01–P 

FEDERAL TRADE COMMISSION 

[File No. 222 3023] 

Lions Not Sheep; Analysis of 

Proposed Consent Order To Aid Public 

Comment 

AGENCY: Federal Trade Commission. 

ACTION: Proposed consent agreement; 

request for comment. 

SUMMARY: The consent agreement in this 

matter settles alleged violations of 

federal law prohibiting unfair or 

deceptive acts or practices. The attached 

Analysis of Proposed Consent Order to 

Aid Public Comment describes both the 

allegations in the draft complaint and 

the terms of the consent order— 

embodied in the consent agreement— 

that would settle these allegations. 

DATES: Comments must be received on 

or before June 21, 2022. 

ADDRESSES: Interested parties may file 

comments online or on paper by 

following the instructions in the 

Request for Comment part of the 

SUPPLEMENTARY INFORMATION section 

below. Please write ‘‘Lions Not Sheep; 

File No. 222 3023’’ on your comment 

and file your comment online at https:// 

www.regulations.gov by following the 

instructions on the web-based form. If 

you prefer to file your comment on 

paper, mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW, Suite 

CC–5610 (Annex D), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW, 

5th Floor, Suite 5610 (Annex D), 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: Julia 

Solomon Ensor (202–326–2377), Bureau 

of Consumer Protection, Federal Trade 

Commission, 600 Pennsylvania Avenue 

NW, Washington, DC 20580. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 6(f) of the Federal Trade 

Commission Act, 15 U.S.C. 46(f), and 

FTC Rule 2.34, 16 CFR 2.34, notice is 

hereby given that the above-captioned 

consent agreement containing a consent 

order to cease and desist, having been 

filed with and accepted, subject to final 

approval, by the Commission, has been 

placed on the public record for a period 

of thirty (30) days. The following 

Analysis to Aid Public Comment 

describes the terms of the consent 

agreement and the allegations in the 

complaint. An electronic copy of the 

full text of the consent agreement 

package can be obtained at https://

www.ftc.gov/news-events/commissionactions. 


jspears on DSK121TN23PROD with NOTICES1
30496 Federal Register / Vol. 87, No. 97 / Thursday, May 19, 2022 / Notices 

You can file a comment online or on 

paper. For the Commission to consider 

your comment, we must receive it on or 

before June 21, 2022. Write ‘‘Lions Not 

Sheep; File No. 222 3023’’ on your 

comment. Your comment—including 

your name and your state—will be 

placed on the public record of this 

proceeding, including, to the extent 

practicable, on the https://

www.regulations.gov website. 

Because of heightened security 

screening, postal mail addressed to the 

Commission will be subject to delay. We 

strongly encourage you to submit your 

comments online through the https://

www.regulations.gov website. 

If you prefer to file your comment on 

paper, write ‘‘Lions Not Sheep; File No. 

222 3023’’ on your comment and on the 

envelope, and mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW, Suite 

CC–5610 (Annex D), Washington, DC 

20580. 

Because your comment will be placed 

on the publicly accessible website at 

https://www.regulations.gov, you are 

solely responsible for making sure your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include sensitive personal information, 

such as your or anyone else’s Social 

Security number; date of birth; driver’s 

license number or other state 

identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure your 

comment does not include sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including competitively sensitive 

information such as costs, sales 

statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the https://

www.regulations.gov website—as legally 

required by FTC Rule 4.9(b)—we cannot 

redact or remove your comment from 

that website, unless you submit a 

confidentiality request that meets the 

requirements for such treatment under 

FTC Rule 4.9(c), and the General 

Counsel grants that request. 

Visit the FTC website at http://

www.ftc.gov to read this document and 

the news release describing the 

proposed settlement. The FTC Act and 

other laws the Commission administers 

permit the collection of public 

comments to consider and use in this 

proceeding, as appropriate. The 

Commission will consider all timely 

and responsive public comments that it 

receives on or before June 21, 2022. For 

information on the Commission’s 

privacy policy, including routine uses 

permitted by the Privacy Act, see 

https://www.ftc.gov/site-information/ 

privacy-policy. 

Analysis of Proposed Consent Order To 

Aid Public Comment 

The Federal Trade Commission 

(‘‘FTC’’ or ‘‘Commission’’) has accepted, 

subject to final approval, an agreement 

containing a consent order from Lions 

Not Sheep Apparel, LLC; Lions Not 

Sheep Products, LLC; Lions Not Sheep 

Ventures, LLC; Lions Not Sheep LLC; 

and Sean Whalen (‘‘Respondents’’). 

The proposed consent order has been 

placed on the public record for thirty 

(30) days for receipt of comments by 

interested persons. Comments received 

during this period will become part of 

the public record. After thirty (30) days, 

the Commission will again review the 

agreement and the comments received 

and decide whether it should withdraw 

from the agreement or make final the 

agreement’s proposed order. 

This matter involves Respondents’ 

advertising of hats, accessories, and 

apparel as ‘‘Made in USA.’’ According 

to the FTC’s complaint, Respondents 

represented that hats and non-apparel 

accessories were all or virtually all 

made in the United States. However, the 

complaint alleges that, in numerous 

instances, those hats and non-apparel 

accessories are wholly imported or 

contain significant imported content. 

Based on the foregoing, the complaint 

alleges Respondents engaged in 

deceptive acts or practices in violation 

of Section 5(a) of the FTC Act. 

The complaint further alleges 

Respondents violated the Textile Fiber 

Products Identification Act by (1) 

advertising articles of wearing apparel 

as of U.S. origin despite the fact they are 

wholly imported or incorporate 

significant imported materials, and (2) 

removing tags containing information 

required pursuant to the Textile Fiber 

Products Identification Act and 

replacing those tags with false countryof-origin designations. 

The proposed consent order contains 

provisions designed to prevent 

Respondents from engaging in similar 

acts and practices in the future. 

Consistent with the FTC’s Made in USA 

Labeling Rule, 16 CFR part 323, and 

Enforcement Policy Statement on U.S.- 

Origin Claims, Part I prohibits 

Respondents from making U.S.-origin 

claims for their products unless: (1) The 

final assembly or processing of the 

product occurs in the United States, all 

significant processing that goes into the 

product occurs in the United States, and 

all or virtually all ingredients or 

components of the product are made 

and sourced in the United States; (2) a 

clear and conspicuous qualification 

appears immediately adjacent to the 

representation that accurately conveys 

the extent to which the product contains 

foreign parts, ingredients or 

components, and/or processing; or (3) 

for a claim that a product is assembled 

in the United States, the product is last 

substantially transformed in the United 

States, the product’s principal assembly 

takes place in the United States, and 

United States assembly operations are 

substantial. 

Part II prohibits Respondents from 

making any representation about a 

product or service, including any 

representation regarding country of 

origin, unless the representation is not 

misleading and Respondents have a 

reasonable basis substantiating it. 

Part III requires Respondents to make 

certain disclosures about the country of 

origin of any product subject to the 

Textile Fiber Products Identification 

Act. 

Parts IV through VI are monetary 

provisions. Part IV imposes a judgment 

of $211,335. Part V includes additional 

monetary provisions relating to 

collections. Part VI requires 

Respondents to provide sufficient 

customer information to enable the 

Commission to administer consumer 

redress, if appropriate. 

Part VII is a notice provision requiring 

Respondents to identify and notify 

certain consumers of the FTC’s action 

within 30 days after the issuance of the 

order, or within 30 days of the 

consumer’s identification, if identified 

later. Respondents are also required to 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 97 / Thursday, May 19, 2022 / Notices 30497 

submit reports regarding their 

notification program. 

Parts VIII through XI are reporting and 

compliance provisions. Part VIII 

requires Respondents to acknowledge 

receipt of the order, to provide a copy 

of the order to certain current and future 

principals, officers, directors, and 

employees, and to obtain an 

acknowledgement from each such 

person that they have received a copy of 

the order. Part IX requires Respondents 

to file a compliance report within one 

year after the order becomes final and to 

notify the Commission within 14 days 

of certain changes that would affect 

compliance with the order. Part X 

requires Respondents to maintain 

certain records, including records 

necessary to demonstrate compliance 

with the order. Part XI requires 

Respondents to submit additional 

compliance reports when requested by 

the Commission and to permit the 

Commission or its representatives to 

interview Respondents’ personnel. 

Finally, Part XII is a ‘‘sunset’’ 

provision, terminating the order after 

twenty (20) years, with certain 

exceptions. 

The purpose of this analysis is to aid 

public comment on the proposed order. 

It is not intended to constitute an 

official interpretation of the proposed 

order or to modify its terms in any way. 

By direction of the Commission. 

April J. Tabor, 

Secretary. 

[FR Doc. 2022–10748 Filed 5–18–22; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to CDC’s Advisory 

Committee to the Director (ACD) Data 

and Surveillance Workgroup (DSW); 

Re-Opening of Solicitation Period 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: Notice is hereby given of a 

change in the solicitation of CDC’s 

Advisory Committee to the Director 

(ACD) Data and Surveillance Workgroup 

(DSW). In the Federal Register notice 

published on May 4, 2022, nominations 

for appointment to CDC’s ACD DSW 

workgroup were due May 16, 2022. 

Nominations are now due May 27, 2022. 

DATES: Nominations for membership on 

the DSW workgroup must be received 

no later than May 27, 2022. Late 

nominations will not be considered for 

membership. 

ADDRESSES: All nominations (cover 

letters and curriculum vitae) should be 

emailed to DSWACD@cdc.gov with the 

subject line: ‘‘Nomination for CDC ACD 

DSW Workgroup.’’ 

FOR FURTHER INFORMATION CONTACT: 

Rachel Holloway, MPH, Office of the 

Chief of Staff, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Mailstop H21–10, Atlanta, 

Georgia 30329–4027; Telephone: (404) 

639–7000; Email: DSWACD@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The purpose of the ACD, 

CDC is to advise the Secretary, HHS, 

and the Director, CDC, on policy and 

broad strategies that will enable CDC to 

fulfill its mission of protecting health 

through health promotion, prevention, 

and preparedness. The ACD, CDC 

consists of up to 15 non-federal 

members, including the Chair, 

knowledgeable in areas pertinent to the 

CDC mission, such as health policy, 

public health, global health, 

preparedness, preventive medicine, the 

faith-based and community-based 

sector, and allied fields. 

Purpose: The establishment and 

formation of the DSW is to provide 

input to the ACD, CDC on agency-wide 

activities related to the scope and 

implementation of CDC’s data 

modernization strategy across the 

agency, ultimately playing a key role in 

the agency’s work with public health, 

healthcare, and academic and private 

sector partners and with the promotion 

of equity. The DSW membership will 

consist of approximately 15 members. It 

will be co-chaired by two current ACD, 

CDC Special Government Employees. 

The DSW co-chairs will present their 

findings, observations, and work 

products at one or more ACD, CDC 

meetings for discussion, deliberation, 

and decisions (final recommendations 

to CDC). 

Nomination Criteria: DSW members 

will serve terms ranging from six 

months to one year and be required to 

attend DSW meetings approximately 

one to two times per month (virtually or 

in person), and contribute time between 

meetings for research, consultation, 

discussion, and writing assignments. 

Nominations are being sought for 

individuals who have the expertise and 

qualifications necessary to contribute to 

the accomplishments of the 

committee’s/workgroup’s objectives. 

Nominees will be selected based on 

expertise in the fields of public health 

science and practice; public health 

preparedness and response; public 

health policy development, analysis, 

and implementation; public health 

surveillance and informatics; data 

analysis, data science, and forecasting; 

health information technology; and 

healthcare delivery from jurisdictional 

government agencies, non-government 

organizations, academia, and the private 

sector. To ensure a diverse workgroup 

composition, nominees with front line 

and field experience at the local, state, 

tribal, and territorial levels are 

encouraged to apply. This includes 

nominees with experience working for, 

and with, community-based 

organizations and other non-profit 

organizations. Federal employees will 

not be considered for membership. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of the DSW’s 

objectives. 

HHS policy stipulates that 

membership be balanced in terms of 

points of view represented and the 

workgroup’s function. Appointments 

shall be made without discrimination 

based on age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens and cannot be fulltime employees of the U.S. Government. 

Current participation on federal 

workgroups or prior experience serving 

on a federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. Interested candidates 

should submit the following items: 

D A one-half to one-page cover letter 

that includes your understanding of, 

and commitment to, the time and work 

necessary; one to two sentences on your 

background and experience; and one to 

two sentences on the skills/perspective 

you would bring to the DSW. 

D Current curriculum vitae which 

highlights the experience and work 

history being sought relevant to the 

criteria set forth above, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

Nominations may be submitted by the 

candidate him or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 


jspears on DSK121TN23PROD with NOTICES1